Miller Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Miller Capital Partners's LLY Position: Q3 2026 in Review
Miller Capital Partners increased its Eli Lilly (LLY) stake by 0.05% in Q3 2026, buying an estimated $2.36K and bringing the position to 3,907 shares worth $4.52M. The position accounts for 1.88% of the portfolio, ranked #11.
Miller Capital Partners first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.68M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Miller Capital Partners held 3,907 shares of Eli Lilly worth $4.52M as of Q3 2026.
- Miller Capital Partners bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
- Eli Lilly made up 1.88% of Miller Capital Partners's portfolio in Q3 2026, its #11 holding.
- Miller Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Miller Capital Partners's Eli Lilly position peaked at $4.68M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Miller Capital Partners's 13F filing for Q3 2026, filed 12 Nov 2026.